NO20083304L - Imidazo(1,2-A)pyridin-3-yl-eddiksyrehydrazider, fremgangsmater for deres fremstilling og farmasoytiske anvendelser derav - Google Patents

Imidazo(1,2-A)pyridin-3-yl-eddiksyrehydrazider, fremgangsmater for deres fremstilling og farmasoytiske anvendelser derav

Info

Publication number
NO20083304L
NO20083304L NO20083304A NO20083304A NO20083304L NO 20083304 L NO20083304 L NO 20083304L NO 20083304 A NO20083304 A NO 20083304A NO 20083304 A NO20083304 A NO 20083304A NO 20083304 L NO20083304 L NO 20083304L
Authority
NO
Norway
Prior art keywords
pyridin
acetic acid
imidazo
acid hydrazides
processes
Prior art date
Application number
NO20083304A
Other languages
English (en)
Norwegian (no)
Inventor
Albert Palomer
Antonio Guglietta
Jose Luis Falco
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO20083304L publication Critical patent/NO20083304L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20083304A 2006-01-03 2008-07-25 Imidazo(1,2-A)pyridin-3-yl-eddiksyrehydrazider, fremgangsmater for deres fremstilling og farmasoytiske anvendelser derav NO20083304L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100030A EP1803722A1 (en) 2006-01-03 2006-01-03 Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
PCT/EP2006/070130 WO2007077159A1 (en) 2006-01-03 2006-12-21 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof

Publications (1)

Publication Number Publication Date
NO20083304L true NO20083304L (no) 2008-09-24

Family

ID=36691692

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083304A NO20083304L (no) 2006-01-03 2008-07-25 Imidazo(1,2-A)pyridin-3-yl-eddiksyrehydrazider, fremgangsmater for deres fremstilling og farmasoytiske anvendelser derav

Country Status (22)

Country Link
US (2) US7943611B2 (pt)
EP (2) EP1803722A1 (pt)
JP (1) JP2009522327A (pt)
KR (1) KR20080083194A (pt)
CN (1) CN101395156B (pt)
AR (1) AR058738A1 (pt)
AT (1) ATE430748T1 (pt)
AU (1) AU2006334364B2 (pt)
BR (1) BRPI0620885A2 (pt)
CA (1) CA2635802A1 (pt)
DE (1) DE602006006725D1 (pt)
DK (1) DK1973907T3 (pt)
ES (1) ES2327278T3 (pt)
IL (1) IL192563A0 (pt)
NO (1) NO20083304L (pt)
PE (1) PE20071059A1 (pt)
PL (1) PL1973907T3 (pt)
PT (1) PT1973907E (pt)
RU (1) RU2008131798A (pt)
TW (1) TW200800992A (pt)
UY (1) UY30066A1 (pt)
WO (1) WO2007077159A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1845098A1 (en) * 2006-03-29 2007-10-17 Ferrer Internacional, S.A. Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
CN109053726A (zh) * 2018-09-14 2018-12-21 烟台万润药业有限公司 一种唑吡坦酸的制备方法
KR102349934B1 (ko) 2020-10-19 2022-01-12 신해찬 층간소음방지부재 및 이를 이용한 층간소음방지층 시공방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU532001B2 (en) * 1978-11-20 1983-09-15 Sumitomo Chemical Company, Limited Polycyclic indole derivatives
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
ES2151834B1 (es) * 1998-08-06 2001-08-16 Sint Quimica Sa Procedimiento para preparar n,n,6-trimetil-2-(4-metilfenil)-imidazo-(1,2-a)-piridina-3-acetamida y sus sales.
US7723324B2 (en) * 2003-10-28 2010-05-25 Sepracor, Inc. Imidazo[1,2-A]pyridine anxiolytics

Also Published As

Publication number Publication date
DK1973907T3 (da) 2009-08-24
KR20080083194A (ko) 2008-09-16
JP2009522327A (ja) 2009-06-11
PT1973907E (pt) 2009-07-28
EP1973907B1 (en) 2009-05-06
ATE430748T1 (de) 2009-05-15
AU2006334364A1 (en) 2007-07-12
TW200800992A (en) 2008-01-01
US20090176777A1 (en) 2009-07-09
CN101395156B (zh) 2011-12-14
EP1803722A1 (en) 2007-07-04
BRPI0620885A2 (pt) 2011-11-29
ES2327278T3 (es) 2009-10-27
PL1973907T3 (pl) 2009-10-30
US20110118256A1 (en) 2011-05-19
US7943611B2 (en) 2011-05-17
HK1123792A1 (en) 2009-06-26
RU2008131798A (ru) 2010-02-10
WO2007077159A1 (en) 2007-07-12
DE602006006725D1 (de) 2009-06-18
AR058738A1 (es) 2008-02-20
EP1973907A1 (en) 2008-10-01
IL192563A0 (en) 2009-02-11
AU2006334364B2 (en) 2011-09-29
CN101395156A (zh) 2009-03-25
PE20071059A1 (es) 2007-10-26
UY30066A1 (es) 2007-04-30
CA2635802A1 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
TWI905095B (zh) 用於治療腦機能障礙的氮呯-吲哚及其他雜環
NO20084375L (no) Imidazo[1,2-B]pyridaziner, deres fremstilling og deres anvendelse som GABA reseptorligander
WO2009120660A3 (en) Substituted pyridoxazines
MX2011008119A (es) Derivado de acido hialuronico polisulfatado de bajo peso molecular, y medicamento que contiene el mismo.
MA32272B1 (fr) Inhibiteurs de raf de pyrazole [3,4-b]pyridine
KR101596607B1 (ko) 이중 활성 H1 역 효능제/5-HT2A 길항제로서의 (티에노[2,3-b][1,5]벤족사제핀-4-일)피페라진-1-일 화합물
JP5281395B2 (ja) 統合失調症の治療用のｇｌｙｔ１阻害剤としてのシクロヘキサンスルホニル誘導体
NO20084997L (no) Pyrazolo[3,4-D]pyrimidinderivater nyttige for a behandle andedrettssykdommer
AU2008329072A1 (en) Aryl and heteroaryl fused imidazo (1,5-A) pyrazines as inhibitors of phosphodiesterase 10
MX2010009658A (es) Derivados de azetidina.
ES2935615T3 (es) Azetidina dihidrotienopiridinas sustituidas y su uso como inhibidores de la fosfodiesterasa
MX2009010731A (es) Derivados de acido 1-(1-bencilpiperidin-4-il)benzimidazol-5-carbox ilico para el tratamiento de diabetes mellitus.
NO20080393L (no) Halogenerte pyrazolo [1,5-A] pyrimidiner, fremgangsmater, anvendelse som GABA-A reseptorligander, sammensetninger og intermediater
JP2019503351A (ja) オピオイド受容体リガンドおよびシトクロムｐ４５０阻害剤の組合せ
MX2009007411A (es) Derivados de espiropiperidina-glicinamida.
AU2017327304B9 (en) Use of morphinan derivative for therapeutic treatment of opioid δ receptor agonist-related disease
CN120202186A (zh) 作为血清素能剂用于治疗与其相关的疾病的3-乙基氨基-吲哚二聚体
JP6416125B2 (ja) ｍＧｌｕＲ３の正のアロステリックモジュレーター
TW200942547A (en) Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
IL206615A (en) The History of Pipridine Sulfonamide, the Process for Preparing it, Medicines Containing It, and Their Use in the Preparation of Medication for Treatment
UY29077A1 (es) Amidas sustituidas de ácido tienopirrolcarboxílico, amidas del ácido pirrolotiazolcarboxílico y análogos relacionados como inhibidores de la caseína cinasa ie(epsilon)
TW200833665A (en) 1H-quinolin-4-one compounds, processes, uses and compositions
RU2387644C2 (ru) Циклопропилпиперидиновые ингибиторы транспортера глицина
NO20090971L (no) 1H-quinolin-4-on forbindelser med affinitet for GABA-receptoren, fremgangsmater, anvendelser og sammensetninger
KR101582429B1 (ko) 이중 활성 H1 역 효능제/5-HT2A 길항제로서의 (티에노[2,3-b][1,5]벤족사제핀-4-일)피페라진-1-일 화합물

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application